Issue Date: June 1, 2009
Dr. Reddy's Folds Drug Discovery Arm
Indian generics producer Dr. Reddy's Laboratories will abandon its proprietary drug discovery efforts but will remain active in drug development. The firm will transfer its drug discovery staff and facilities in Hyderabad to its contract research subsidiary Aurigene. As part of the reorganization, Dr. Reddy's will close an R&D lab in Atlanta. The firm says it will still conduct drug development work by licensing promising drug candidates from Aurigene and others.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society